Role of three cancer 'master genes' p53, bcl2 and c-myc on the apoptotic process

Tumori

Volumn 82, Issue 3, 1996, Pages 205-209

  Chiarugi, Vincenzo ^a,b   Ruggiero, Marco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Institute of General Pathology   (Italy)

Author keywords

apoptosis; bcl2; ionizing radiation; myc; oncogenes; p53; tumor suppressor genes

Indexed keywords

CYCLINE; PROTEIN P53;

APOPTOSIS; CANCER RESISTANCE; CELL CYCLE G1 PHASE; GROWTH DISORDER; IONIZING RADIATION; ONCOGENE; ONCOGENE C MYC; RECEPTOR DOWN REGULATION; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; GENES, MYC; GENES, P53; HUMANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0029900983     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Amati B., Dalton S., Brooks M.V., Littlewood G., Evan L., Land H.: Transcriptional activation by human c-myc oncoprotein in yeast requires interaction with Max. Nature, 359: 423-426, 1992.
2. Baffy G., Miyashita T., Williamson J.R., Reed J.C.: Apoptosis induced by withdrawal of interleukin-3 (IL3) from IL3-dependent hematopoietic cell line is associated in repartitioning of intracellular calcium and is blocked by enforced bcl2 oncoprotein production. J. Biol. Chem., 268: 6511-6519, 1993.
3. Bissonette R.P., Acheverry F., Malabouty A., Green D.R.: Apoptotic cell death induced by c-myc is inhibited by bcl2. Nature, 359: 552-554, 1992.
4. Blackwood E.M., Eiseman J.K.: Max: an helix-loop-helix zipper protein that forms a sequence-specific DNA binding complex with myc. Science, 250: 1149-1151, 1991.
5. Brachman D.G., Beckett M., Graves D., Yokes E., Weichselbaum R.R.: p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res., 53: 3667-3669, 1993.
6. Brendan D.P., Calderwood S.K.: Increased sequence-specific p53 DNA binding activity after DNA damage is attenuated by phorbol esters. Oncogene, 8: 3055-3062, 1993.
7. Caelles C., Holmberg A., Karin M.: p53-dependent apoptosis in the absence of transcriptional activation target genes. Nature, 370: 220-223, 1994.
8. Chiarugi V., Magnelli L., Cinelli M., Basi G.: Apoptosis and the cell cycle. Cell. Mol. Biol. Res., 40: 603-612, 1994.
9. Chiou S., Rao L., White E.: bcl2 blocks p53-dependent apoptosis. Mol. Cell. Biol., 14: 2556-2563, 1994.
10. Clarke A.R., Purdie C.A., Harrison D.J., Morris R.G., Bird C.C., Hooper L., Wyllie A.H.: Thymocyte apoptosis induced by p53-dependent and -independent pathways. Nature, 362: 849-852, 1993.
11. Cox A.D., Brtva T.R., Lowe D.G., Der C.J.: R-ras induces malignant, but not morphologic, transformation of NIH/3T3 cells. Oncogene, 11: 3281-3289, 1994.
12. Cross S.M., Sanchez C.A., Morgan C.A., Shimke M.K., Ramel S., Idzerda R.L., Raskin W.H., Reid B.J.: p53-dependent mouse spindle checkpoint. Science, 267: 1353-1356, 1995.
13. De Jong D., Prins F.A., Mason D.Y., Reed J.C., Van Omnen G.B., Kluin P.M.: Subcellular localization of the bcl2 protein in malignant and normal lymphoid cells. Cancer Res., 54: 256-260, 1994.
14. Eilers M., Schirm S., Bishop J.M.: The myc protein activates transcription of the alpha-protothymosin gene. EMBO J., 10: 133-141, 1991.
15. El Deiry W.S., Harper J.W., O'Connor P.M., Velculescu V.E., Canman C.E., Kastan E., Kohon K.W., Elledge S.J., Kinzler K.W., Vogelstein B.: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
16. Evan G.I., Wyllie C.S., Gilbert T.D., Littlewood H.L., Brooks M., Waters C.M., Penn L.Z., Hancock D.C.: Induction of apoptosis in fibroblasts by the c-myc protein. Cell, 68: 122-128, 1992.
17. Fan S., Smith M.L., Rivet D.J., Duba D., Zhan Q., Kohon K.W., Fornace A.J., O'Connor P.M.: Disruption of p53 function sensitize breast cancer MCF-7 cells to cisplatin and pentoxiphylline. Cancer Res., 55: 1649-1654, 1995.
18. Fanidi A., Harrington E.A., Evan G.I.: Cooperative interaction between c-myc and bcl2 proto-oncogene. Nature, 359: 554-559, 1992.
19. Fernandez-Sarabia M.J., Bichoff J.R.: bcl2 associates with ras-related protein R-ras-p23. Nature, 366: 554-559, 1992.
20. Goruppi S., Gustinchich S., Brancolini C., Lee W., Schneider C.: Dissection of myc domains involved in S phase induction in NIH/3T3 cells. Oncogene, 9: 1537-1544, 1994.
21. Harper J.W., Adami G.R., Wei N., Keiomarsi G., Elledge S.I.: The p21-CDK-interacting protein CIP1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
22. Hochembery D., Oltvai Z.M., Yin X.M., Milliman C., Korsmeyer S.J.: bcl2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75: 241-251, 1993.
23. Hochembery D., Zutter M., Hickey W., Naham M., Korsmeyer S.J.: bcl2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. U.S.A., 88: 6961-6965, 1991.
24. Hoffman B., Lieberman D.A.: Molecular control of apoptosis: differentiation/growth arrest, primary cells, protooncogenes, and tumor suppressor genes as positive and negative regulators. Oncogene, 12: 1807-1812, 1994.
25. Jacobson M.D., Burne J.F., King M.P., Miyashita T., Reed J.C., Raff M.C.: bcl2 blocks apoptosis in cells lacking mitochondrial DNA. Nature, 361: 365-368, 1993.
26. Jansen-Durr P., Meichle A., Steiner P., Pagano M., Finke K., Botz J., Wessbecher J., Draetta G., Eilers M.: Differential modulation of cyclin gene expression by c-myc. Proc. Natl. Acad. Sci. U.S.A., 90: 3685-3689, 1993.
27. Jiang W.S., Kahan M., Zhang Y., Cacace A., Weinstein I.B.: Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control of cell cycle progression and gene expression. Oncogene, 8: 773-787, 1993.
28. Kane D.J., Serafin T.A., Anton R., Hahn H., Buter-Galla E., Silverstone-Valentine J., Ord T.D.E., Bredsen D.E.: bcl2 inhibition of neural death: decreased generation of reactive oxygen species. Science, 263: 1264-1267, 1993.
29. Korsmeyer S.J.: bcl2 initiates a new category of oncogenes: regulators of cell death. Blood, 80: 876-886, 1992.
30. Lowe S.W., Ruley H.E., Jacks T., Hanson D.O.: p53-dependent apoptosis modulate the cytotoxicity of anticancer agents. Cell, 47: 957-967, 1993.
31. Lu L., Hamby A.M., Hajibagheri M.A., Geshmeissner S.E., Lu P.J., Papadimitru J., Krajeswky S., Rees J.C., Wright N.A.: bcl2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines. J. Cell. Sci., 107: 363-371, 1994.
32. Lu X., Park S.H., Thompson T.C., Lane D.P.: Ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation. Cell, 70: 153-161, 1992.
33. Magnelli L., Cinelli M., Turchetti A., Chiarugi V.P.: bcl2 overexpression abolishes early calcium waveing preceding apoptosis in NIH/3T3 rnurine fibroblasts. Biochem. Biophys. Res. Commun., 204: 84-90, 1994.
34. McDonnell T.J., Korsmeyer S.J.: Progression from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for (t-14/18). Nature, 349: 254-256, 1991.
35. McIlwrath A., Vosey P., Ross G.M., Brown R.: Cell arrest and radiosensitivity of human tumor cell lines: dependence of wild-type p53 for radiosensitivity. Cancer Res., 54: 3718-3722, 1994.
36. Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K., Lieberman D.A., Hoffman B., Reed J.C.: Tumor suppressor p53 is a regulator of bcl2 and bax gene expression in vitro and in vivo. Oncogene, 9: 1799-1805, 1994.
37. Nowell P.C., Croce C.M.: Cytogenetics of neoplasia. In: Development and recognition of transformed cells. Green M.I. and Hanaoka T. (Eds.), Plenum, New York, 1987.
38. Oswald F., Lovec H., Moroy T., Lipp M.: E2F-dependent regulation of human myc transactivation by cyclins D1 and A overrides tumor suppressor protein functions. Oncogene, 9: 2029-2036, 1994.
39. Phillipp A., Schneider A., Vasrik I., Finke K., Xiong Y., Beach D., Alitalo K., Eilers M.: Repression of cyclin D1: a novel function of myc? Mol. Cell. Biol., 14: 4032-4043, 1994.
40. Powell S.N., DeFrank J.S., Cornell P., Preffer F., Domkowski D., Friend S.: Differential sensitivity of p53- and p53+ cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res., 55: 1643-1648, 1995.
41. Reed J.C.: bcl2 and the regulation of programmed cell death. J. Cell. Biol., 124: 1-6, 1994.
42. Rey I., Taylor-Harris P., Van Erp H., Hall A.: R-ras interacts with ras-GTP, neurofibromin and c-raf but does not regulate cell growth and differentiation. Oncogene, 9: 685-692, 1994.
43. Rowley R.: Reduction of radiation-induced G2 arrest by caffeine. Radiat. Res., 129: 224-227, 1992.
44. Russell K.J., Wiens L.W., Demers G.W., Galloway D.A., Plon S.E., Groudine M.: Abrogation of G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells. Cancer Res., 55:1639-1642, 1995.
45. Ryan J.J., Danish R., Gottliebel C.A., Clarke M.F.: p53 induces apoptosis in G1 in hematopoietic cells. Mol. Cell. Biol., 13: 711-719, 1993.
46. Ryan J.J., Prochownik E., Gottliebel C.A., Apel I.J., Merino R., Nunez G., Clarke M.F.: c-myc and bcl2 modulate p53 function by altering p53 subcellular trafficking during cell cycle. Proc. Natl. Acad. Sci. U.S.A., 91: 5878-5882, 1994.
47. Schultze-Osthoff K., Walczak H., Droge W., Krammer P.H.: Cell nucleus and DNA fragmentation are not required for apoptosis. J. Cell. Biol., 127: 15-20, 1994.
48. Selvakuran M., Lin H., Sjin R., Reed J.C., Lieberman D.A., Hoffman B.: The novel primary response of gene myd-118 and the protooncogenes myb, myc, and bcl2 modulate transforming growth factor beta-1-induced apoptosis in myeloid leukemia. Mol. Cell. Biol., 14: 2352-2360, 1994.
49. Sherr C.J.: Mammalian G1 cyclins. Cell, 73: 1059-1065, 1993.
50. Silvestrini R., Veneroni S., Daidone M.G., Benini E., Borracchi P., Mezzetti M., Di Fronzo G., Rilke F., Veronesi U.: The bcl2 protein: a prognostic indicator strongly related to p53 protein in lymphnode-negative breast cancer patients. J. Natl. Cancer Inst., 86: 499-504, 1994.
51. Slinchenmeyer W.I., Nelson G.W., Slebos R.J., Kasta M.B.: Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res., 53: 4164-4168, 1993.
52. Smith M.L., Chen I.T., Zhan Q., Bae I., Chen C.Y., Gilmer T.M., Kastan M.B., O'Connor P.M., Fornace A.J. Jr.: Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science, 266: 1376-1380, 1994.
53. Steward N., Hicks G., Paraskevas F., Movat M.: Evidence for a second cell cycle block at G2/M by p53. Oncogene, 10: 109-115, 1995.
54. Wang H.G., Miyashita T., Tokoyama S., Sato T., Torigoe T., Krajewski S., Tanaka S., Harvey L., Troppmair J., Rapp U.R.: Apoptosis regulation by interaction of bcl2 protein and raf1 kinase. Oncogene, 9: 2751-2756, 1994.
55. Wang Y., Szekely L., Okan I., Klei G., Wiman K.G.: p53-triggered apoptosis is inhibited by bcl2 in a v-myc-induced cell lymphoma line. Oncogene, 8: 3427-3431, 1993.
56. Weinert T.A., Hartwell L.H.: The rad9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science, 241: 317-321, 1988.
57. Xiong Y., Hannon G., Zhang H., Casso D., Kobayashi R., Beach D.: p21 is universal inhibitor of cyclin kinases. Nature, 366: 701-705, 1993.